- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.10. | Rapid Dose Therapeutics Corp: Rapid Dose closes final tranche of financing | 1 | Stockwatch | ||
| 30.10. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Closing of Final Tranche of Common Share Private Placement | 311 | Newsfile | Burlington, Ontario--(Newsfile Corp. - October 30, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to announce that it has closed a second and final tranche of... ► Artikel lesen | |
| 02.10. | Rapid Dose Therapeutics Corp: Rapid Dose to issue 557,677 shares for debt | 3 | Stockwatch | ||
| 02.10. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Payment in Shares for Interest on Secured Debt | 433 | Newsfile | Burlington, Ontario--(Newsfile Corp. - October 1, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the... ► Artikel lesen | |
| 17.09. | Rapid Dose Therapeutics Corp: Rapid Dose extends private placement to Oct. 29 | 4 | Stockwatch | ||
| RAPID DOSE THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 17.09. | Rapid Dose Therapeutics Corp.: Rapid Dose Provides Update on Common Share Private Placement | 449 | Newsfile | Burlington, Ontario--(Newsfile Corp. - September 16, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated August 7, 2024... ► Artikel lesen | |
| 22.07. | Rapid Dose Therapeutics Corp: Rapid Dose closes $309,000 first tranche of financing | 4 | Stockwatch | ||
| 22.07. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Closing of First Tranche of Common Share Private Placement | 249 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 22, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to announce that it has closed a first tranche of its previously... ► Artikel lesen | |
| 03.07. | Rapid Dose Therapeutics Corp: Rapid Dose to issue 520,968 shares for note interest | 1 | Stockwatch | ||
| 03.07. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Announces Payment in Shares for Interest on Secured Debt | 492 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the... ► Artikel lesen | |
| 02.07. | Rapid Dose Therapeutics Corp: Rapid Dose loses $4.28-million in fiscal 2024 | 1 | Stockwatch | ||
| 02.07. | Rapid Dose Therapeutics GAAP EPS of -C$0.04, revenue of C$1.02M | 1 | Seeking Alpha | ||
| 02.07. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Reports Fiscal Year 2024 Financial Results | 243 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), is pleased to announce the filing of its financial results for the year ended... ► Artikel lesen | |
| 25.06. | Rapid Dose Therapeutics Corp: Rapid Dose receives $30,000 grant for vaccine study | 1 | Stockwatch | ||
| 25.06. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Vaccine Delivery Study Receives Mitacs Accelerate Grant | 202 | Newsfile | Burlington, Ontario--(Newsfile Corp. - June 25, 2024) - Rapid Dose Therapeutics Corp. ("RDT" or the "Company") trading on the Canadian Securities Exchange ("CSE") under the symbol DOSE is pleased to... ► Artikel lesen | |
| 19.06. | Rapid Dose Therapeutics Corp: Rapid Dose Therapeutics extends $6M financing to Aug. 8 | 1 | Stockwatch | ||
| 19.06. | Rapid Dose Therapeutics Corp.: Rapid Dose Provides Update on Common Share Private Placement | 271 | Newsfile | Burlington, Ontario--(Newsfile Corp. - June 19, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated May 8, 2024, regarding... ► Artikel lesen | |
| 31.05. | PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics Commits to NFL-Funded Clinical Trial Application | 317 | Dow Jones News | DJ PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics Commits to NFL-Funded Clinical Trial Application
Unternehmensmitteilung für den Kapitalmarkt
Burlington (pta/31.05.2024/11:16)... ► Artikel lesen | |
| 29.05. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Commits to NFL-Funded Clinical Trial Application | 311 | Newsfile | Burlington, Ontario--(Newsfile Corp. - May 29, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces its collaboration in the National Football League (NFL) - funded... ► Artikel lesen | |
| 23.05. | PTA-News: Rapid Dose Therapeutics Inc.: Incorporation of Loratadine-Cyclodextrin Complexes in Oral Thin Films ("OTF") for Rapid Drug Delivery | 352 | Dow Jones News | DJ PTA-News: Rapid Dose Therapeutics Inc.: Incorporation of Loratadine-Cyclodextrin Complexes in Oral Thin Films ("OTF") for Rapid Drug Delivery
Unternehmensmitteilung für den Kapitalmarkt
... ► Artikel lesen |
Seite:
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 111,10 | -0,45 % | Evotec, Vidac Pharma, BioNTech - Krebsforschung: Die Goldgrube im Depot | Investitionen in Aktiengesellschaften, die im Bereich der Onkologieforschung tätig sind, bieten vielversprechende Renditechancen und langfristige Stabilität. Der Onkologiemarkt gehört zu den wachstumsstärksten... ► Artikel lesen | |
| CORE ONE LABS | 0,079 | -100,00 % | Prusa CORE One: Prusa veröffentlicht STEP- und STL-Dateien | ||
| CLINUVEL | 7,980 | +0,13 % | Clinuvel Pharmaceuticals Aktie: Keine rosigen Aussichten | Die Clinuvel Pharmaceuticals Aktie zeigt zum Ende des Jahres 2024 eine deutliche Schwächephase. Der aktuelle Kursstand von 8,093 EUR (Stand: 30. November) spiegelt einen beträchtlichen monatlichen Rückgang... ► Artikel lesen | |
| BIONXT SOLUTIONS | 0,217 | +5,85 % | BioNxt Solutions kündigt Entwicklung eines sublingualen Schmelzfilms für Semaglutid an | VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / 2. Dezember 2024 / BioNxt Solutions Inc. ("BioNxt" oder das
"Unternehmen") (CSE: BNXT / OTC-MÄRKTE: BNXTF / FWB: BXT), ein auf fortschrittliche Arzneimittelverabreichungssysteme... ► Artikel lesen | |
| AMYRIS | - | - | BioMaP-Consortium Contracts Amyris to Support Domestic Medicines Supply | ||
| ATAI LIFE SCIENCES | 1,550 | -4,03 % | Psychedelic drug developer Atai rises as RFK Jr picked for top US health agency role | ||
| VIDAC PHARMA | 0,580 | 0,00 % | Wer profitiert, wer verliert? Bayer, Formycon, Regeneron Pharmaceuticals, Vidac Pharma Aktie | In einem Interview mit der Zeitung Les Echos äußerte sich der Chefvolkswirt der Europäischen Zentralbank (EZB), Philip Lane, dass er noch nicht bereit ist einen Sieg über die Inflation zu erklären.... ► Artikel lesen | |
| MUSTGROW BIOLOGICS | 1,195 | -0,83 % | MustGrow Biologics Corp.: MustGrow Biologics Signs Non-Binding Term-Sheet for Acquisition of NexusBioAg | Saskatoon, Saskatchewan--(Newsfile Corp. - November 27, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce the signing of a... ► Artikel lesen | |
| ENTHEON BIOMEDICAL CORP | 0,080 | 0,00 % | Entheon Biomedical Corp (2): Entheon Biomedical arranges $300,000 private placement | ||
| CARA THERAPEUTICS | 0,243 | -2,41 % | Cara Therapeutics, Inc.: Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica | - Oral difelikefalin did not demonstrate meaningful clinical benefit compared to placebo - - Company will discontinue clinical program in NP and explore strategic alternatives - STAMFORD, Conn., June... ► Artikel lesen | |
| REVIVE THERAPEUTICS | 0,001 | -85,71 % | Revive Therapeutics Ltd.: Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure and Expansion into Viral Infections | TORONTO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research... ► Artikel lesen | |
| CYBIN | 9,450 | -0,53 % | Cybin Initiates PARADIGM: A Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder and Reports Second Quarter Financial Results | TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare... ► Artikel lesen | |
| SOL GLOBAL INVESTMENTS | 0,149 | +10,37 % | SOL Global Investments Corp.: SOL Global Announces Closing of C$3.6 Million Brokered Private Placement of Units | Toronto, Ontario--(Newsfile Corp. - December 3, 2024) - SOL Global Investments Corp. (CSE: SOL) (OTC Pink: SOLCF) (FSE: 9SB) ("SOL Global" or the "Company") is pleased to announce that it has closed... ► Artikel lesen | |
| AWAKN LIFE SCIENCES | 0,095 | +38,97 % | Awakn Life Sciences Corp.: Awakn Announces Opening of Four Additional AWKN-001 Phase 3 Trial Sites | Toronto, Ontario--(Newsfile Corp. - October 22, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing... ► Artikel lesen | |
| ARTELO BIOSCIENCES | 1,070 | -0,93 % | Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium | SOLANA BEACH, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments... ► Artikel lesen |
RAPID DOSE THERAPEUTICS CORP gehört der Branche Biotechnologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RAPID DOSE THERAPEUTICS CORP finden Sie auf Wallstreet Online.
